JO
LOXO

John Overdeck’s Loxo Oncology, Inc LOXO Stock Holding History

John Overdeck’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-22,052
Closed -$1.77M – 3409
2017
Q2 		$1.77M Buy
+22,052
New +$1.22M 0.01% 1506
2016
Q1 		– Sell
-20,324
Closed -$578K – 3278
2015
Q4 		$578K Buy
+20,324
New +$545K ﹤0.01% 1881

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

John Overdeck's LOXO Position: Q3 2017 in Review

John Overdeck sold out of Loxo Oncology, Inc (LOXO) in Q3 2017, closing a stake of 22,052 shares — an estimated $1.77M sold.

John Overdeck first reported a position in LOXO in Q4 2015 and held it in 2 quarters. The position peaked at $1.77M in Q2 2017. 148 funds tracked by Wall St. Rank hold LOXO as of Q3 2017.

  • John Overdeck reported no remaining Loxo Oncology, Inc position as of Q3 2017 after selling out during the quarter.
  • John Overdeck sold 22,052 Loxo Oncology, Inc shares in Q3 2017, an estimated $1.77M.
  • John Overdeck first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 2 quarters.
  • John Overdeck's Loxo Oncology, Inc position peaked at $1.77M in Q2 2017.
  • 148 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2017.

Based on Two Sigma Investments's 13F filing for Q3 2017, filed 14 Nov 2017.